Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
McKinsey
Harvard Business School
Baxter
Cerilliant
Fuji
Cantor Fitzgerald
Novartis
US Department of Justice

Generated: February 22, 2018

DrugPatentWatch Database Preview

FABIOR Drug Profile

« Back to Dashboard

Which patents cover Fabior, and what generic alternatives are available?

Fabior is a drug marketed by Mayne Pharma and is included in one NDA. There is one patent protecting this drug.

This drug has nineteen patent family members in thirteen countries.

The generic ingredient in FABIOR is tazarotene. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
Drug patent expirations by year for FABIOR
Pharmacology for FABIOR
Ingredient-typeRetinoids
Drug ClassRetinoid

US Patents and Regulatory Information for FABIOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma FABIOR tazarotene AEROSOL, FOAM;TOPICAL 202428-001 May 11, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for FABIOR

Supplementary Protection Certificates for FABIOR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0008 Belgium ➤ Try a Free Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203
C/GB98/002 United Kingdom ➤ Try a Free Trial PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730
/1998 Austria ➤ Try a Free Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
McKesson
Cerilliant
Moodys
Boehringer Ingelheim
Farmers Insurance
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot